# Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia

> **NCT02716818** · PHASE3 · COMPLETED · sponsor: **Neurocrine UK Limited** · enrollment: 122 (actual)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **DRUG:** Chronocort®
- **DRUG:** standard glucocorticoid therapy

## Key facts

- **NCT ID:** NCT02716818
- **Lead sponsor:** Neurocrine UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-22
- **Primary completion:** 2018-07-28
- **Final completion:** 2018-07-28
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716818, "Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02716818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*